SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-002717
Filing Date
2022-03-03
Accepted
2022-03-03 07:15:44
Documents
14
Period of Report
2022-03-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pasg-20220303x8k.htm   iXBRL 8-K 44406
2 EX-99.1 pasg-20220303xex99d1.htm EX-99.1 120043
3 GRAPHIC pasg-20220303xex99d1002.jpg GRAPHIC 2744
  Complete submission text file 0001558370-22-002717.txt   304616

Data Files

Seq Description Document Type Size
4 EX-101.SCH pasg-20220303.xsd EX-101.SCH 3055
5 EX-101.LAB pasg-20220303_lab.xml EX-101.LAB 16585
6 EX-101.PRE pasg-20220303_pre.xml EX-101.PRE 10465
8 EXTRACTED XBRL INSTANCE DOCUMENT pasg-20220303x8k_htm.xml XML 5008
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39231 | Film No.: 22706733
SIC: 2836 Biological Products, (No Diagnostic Substances)